Prolonged Anesthesia Induction to Delivery Time Did Not Influence Plasma Remifentanil Concentration in Neonates
Meng Cai,Hao Liu,Yong Peng,Jing-Kun Miao,Xiao-Feng Lei,Jin Yu
DOI: https://doi.org/10.2147/dddt.s407602
2023-05-09
Abstract:Meng Cai, 1 Hao Liu, 2 Yong Peng, 2 Jing-Kun Miao, 2 Xiao-Feng Lei, 1 Jin Yu 1 1 Department of Anesthesiology, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China; 2 Department of Pediatrics, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China Correspondence: Jin Yu, Department of Anesthesiology, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, No. 120, Longshan Road, Yubei District, Chongqing, 401147, People's Republic of China, Tel +86-18623117820, Email Objective: Remifentanil, in combination with etomidate and sevoflurane, is commonly used in clinics for general anesthesia induction in cesarean section (CS). This study aimed to evaluate the correlation between the induction to delivery (I-D) time and neonatal plasma drug concentration and anesthesia, as well as its effects on neonates. Methods: Fifty-two parturients in whom general anesthesia was induced for CS were divided into group A (I-D< 8 min) and group B (I-D≥ 8 min). Maternal arterial (MA), umbilical venous (UV), and umbilical arterial (UA) blood samples were collected at delivery to analyze the remifentanil and etomidate concentrations using liquid chromatography-tandem mass spectrometry. Results: There were no statistically significant differences between the two groups in terms of plasma concentrations of remifentanil in the MA, UA, and UV blood (P > 0.05). The plasma concentration of etomidate in MA and UV was higher in group A than that in group B (P< 0.05), whereas the UA/UV ratio of etomidate was higher in group B than that in group A (P 0.05). The concentrations of etomidate in the MA and UV were negatively correlated with the I-D time (P < 0.05). Conclusion: Prolonged I-D time did not significantly influence the maternal or neonatal plasma concentration of remifentanil. It is safe to administer remifentanil target-controlled infusion in combination with etomidate and sevoflurane for general anesthesia induction during CS. Keywords: cesarean section, placental transport, general anesthesia, remifentanil, etomidate, drug concentration The greatest risk for parturients contraindicated for intraspinal anesthesia for cesarean section (CS) is the side effect of the anesthetics used in the induction of general anesthesia on the neonate. 1,2 Although the placenta acts as a protective barrier, the degree of protection varies for different drugs and depends on multiple factors, such as lipid solubility, molecular weight, binding to maternal and fetal plasma proteins, and transporter-mediated efflux. 3 Opioid analgesics, such as remifentanil, which have the pharmacokinetic features of rapid onset and offset durations, have been used at different doses with different application methods for anesthesia induction and maintenance in CS. The fentanyl fetus/placenta area under the curve (AUC) ratio has been reported as 39.1%. 3 Remifentanil crosses the placenta and is quickly cleared from neonatal circulation. Pre-delivery remifentanil administration had no significant effect on the neonatal Apgar scores at 1 and 5 min or respiratory interventions required at birth. 4 An early study 5 reported that remifentanil alone can easily penetrate the placenta when used at low concentrations, and the maternal artery/umbilical arterial (MA/UA) ratio was 0.88. Another study 6 on the placental transport rate of remifentanil reported that when combined with propofol, the umbilical venous (UV)/MA ratio was 63%. However, no significant serious adverse effects of the anesthetic drugs on neonatal outcomes at childbirth were reported in most of these studies. Another well-known and widely used drug for general anesthesia induction in CS is etomidate, 7 which is cleared rapidly and does not cause myocardial or respiratory depression or hypotension. Notably, etomidate has been reported to have greater advantages for mothers with congenital heart disease previously. 8,9 According to a previous study, the UV/MA ratio of etomidate was 86%. 10 The potential adverse effects of general anesthetics on neonates depend on the plasma concentration of the drug and maybe the duration between anesthesia induction and delivery. However, there are concerns that a longer interval between anesthesia induction and f -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal